null

FITC Anti-Human CD134 Antibody [Ber-ACT35] (AGEL1785)

SKU:
AGEL1785
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Reactivity:
Human
Applications:
FC
€169 - €579
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

FITC Anti-Human CD134 Antibody [Ber-ACT35]

The Human CD134 Monoclonal Antibody FITC Conjugated (BER-ACT35) is a high-quality antibody specifically designed for research purposes involving the CD134 protein, a cell surface molecule known for its role in immune responses and T-cell activation. This monoclonal antibody, conjugated with FITC for fluorescence detection, is validated for use in flow cytometry applications, making it a valuable tool for analyzing and detecting CD134 expression in human samples. CD134, also known as OX40, is a co-stimulatory receptor expressed on activated T cells and plays a crucial role in regulating immune responses and promoting T-cell survival.

Its involvement in modulating T-cell function and cytokine production makes it an important target for studies in immunology, vaccine development, and autoimmune diseases. By targeting CD134, researchers can investigate its impact on immune cell activation and potential therapeutic interventions aimed at modulating immune responses in various disease settings. The Human CD134 Monoclonal Antibody FITC Conjugated (BER-ACT35) offers precise and reliable detection of CD134, making it an essential tool for furthering research in immunology and related fields.